"For too long, and without any transparency, pharmacy middlemen have moved away from their origins negotiating to bring prices down on behalf of insurers and consumers and have instead moved toward extracting profit, leading to higher drug prices, more federal spending, and bigger out-of-pocket costs for Virginians. The Inflation Reduction Act we enacted last year finally gave Medicare the power to negotiate prices for some of the most expensive prescription drugs for seniors on Medicare, but Congress needs to do more to lower the price of medicines, including through reforms to PBMs. I'm proud of our work today in the Finance Committee, and am hopeful that we can bring a bill to the Senate floor and get it to the president's desk soon."